COVID-19
Latest discoveries

EU regulators start review of China's Sinovac vaccine

Updated: 2021-05-04 19:05
A worker from Sinovac Research & Development Co Ltd checks labels on the bottles of vaccines at an automatic bottling line, Jan 6, 2021. [Photo/Xinhua]

THE HAGUE, Netherlands — The European Union's drug regulator says it has started a rolling review of China's Sinovac coronavirus vaccine to assess its effectiveness and safety, a first step toward possible approval for use in the 27-nation bloc.

The European Medicines Agency said Tuesday that its decision to start the review is based on preliminary results from laboratory studies and clinical studies.

"These studies suggest that the vaccine triggers the production of antibodies" that fight the coronavirus "and may help protect against the disease," the agency said in a statement. The EMA added that no application has yet been submitted for marketing authorization for the vaccine.

During a rolling review, drugmakers submit their study data in increments instead of waiting for research to be completed in order to speed up the process. The European Union has faced pressure to speed up the pace of its vaccine acquisition program.

- AP

Please feel free to contact us by sending your questions to question@njylgcgl.org or commenting on China Daily app. We will ask experts to answer them.

Editor's picks
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US